The Role of Soluble 5’-Nucleotidases in the Conversion of Nucleotide Analogs: Metabolic and Therapeutic Aspects

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|20|34|4249-4259

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.20, Iss.34, 2013-11, pp. : 4249-4259

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial:Metabolic, Pathological, and Therapeutic Perspectives Intracellular 5’-Nucleotidases.

By  

Current Medicinal Chemistry, Vol. 20, Iss. 34, 2013-11 ,pp. : 4203-4204

Bentham Science Publishers

Access to resources Recommend Favorite

5’-Nucleotidases, Nucleosides and their Distribution in the Brain: Pathological and Therapeutic Implications

By  

Current Medicinal Chemistry, Vol. 20, Iss. 34, 2013-11 ,pp. : 4217-4240

Bentham Science Publishers

Access to resources Recommend Favorite

Is the Expression of Deoxynucleoside Kinases and 5’-nucleotidases in Animal Tissues Related to the Biological Effects of Nucleoside Analogs?

By  

Current Medicinal Chemistry, Vol. 20, Iss. 34, 2013-11 ,pp. : 4241-4248

Bentham Science Publishers

Access to resources Recommend Favorite

The Functional Logic of Cytosolic 5’-Nucleotidases.

By  

Current Medicinal Chemistry, Vol. 20, Iss. 34, 2013-11 ,pp. : 4205-4216

Bentham Science Publishers

Access to resources Recommend Favorite

Release of soluble nucleotidases: a novel mechanism for neurotransmitter inactivation?

By Kennedy C.   Todorov L.D.   Mihaylova-Todorova S.   Sneddon P.  

Trends in Pharmacological Sciences, Vol. 18, Iss. 8, 1997-08 ,pp. : 263-266

Elsevier

Access to resources Recommend Favorite